Skip to content

Clinical trials

Ischemic Stroke trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Country / region: China Clear all

716 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20062
20071
20083
20093
20101
20114
201211
201317
201412
201510
201621
201718
201838
201927
202031
202153
202263
202389
2024101
2025103
2026105

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting213
Completed213
Unknown status169
Not yet recruiting83
Active, not recruiting12
Terminated12
Enrolling by invitation6
Withdrawn5
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital75
Xuanwu Hospital, Beijing42
Capital Medical University40
General Hospital of Shenyang Military Region34
Second Affiliated Hospital, Zhejiang University, School of Medicine22
Yi Yang18
Xijing Hospital17
Dongzhimen Hospital, Beijing14
Nanfang Hospital, Southern Medical University13
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke716
Stroke110
Ischemic Attack, Transient16
Atrial Fibrillation15
Cerebrovascular Disorders15
Cerebral Infarction13
Brain Infarction12
Intracranial Arteriosclerosis12
Thrombosis11
Brain Diseases10

Trials

Showing 76 to 100 of 716. Each trial links to its page on Pharma Observatory.

616 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.